hESC-derived neural progenitors prevent xenograft rejection through neonatal desensitisation

Stem cell therapies for neurological disorders are rapidly moving towards use in clinical trials. Before initiation of clinical trials, extensive pre-clinical validation in appropriate animal models is essential. However, grafts of human cells into the rodent brain are rejected within weeks after tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Heuer, Andreas, Kirkeby, Agnete, Pfisterer, Ulrich, Jönsson, Marie E., Parmar, Malin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academic Press 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920671/
https://www.ncbi.nlm.nih.gov/pubmed/27235932
http://dx.doi.org/10.1016/j.expneurol.2016.05.027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920671/
https://www.ncbi.nlm.nih.gov/pubmed/27235932
http://dx.doi.org/10.1016/j.expneurol.2016.05.027

Ejemplares similares